Multimorbidity and Frailty in Older Adults: Clinical and Therapeutic Challenges

Résumé

This is the 2026 João Monjardino Prize, a competitive award established under a protocol between the Foundation for Science and Technology (FCT) and the Professor Francisco Pulido Valente Foundation. The prize recognizes the best scientific article published on the theme of multimorbidity and frailty in older adults: clinical and therapeutic challenges, authored by researchers affiliated with Portuguese scientific and technological institutions. Applications close on 30 September 2026.

This call is a biomedical research prize focused on multimorbidity and frailty in older adults, which is entirely outside Acme Corporation's semiconductor and AI domains. The call targets individual researchers at Portuguese institutions for published articles, not industrial companies or technology development projects. There is no overlap with the client's core competencies or strategic priorities.

Scores détaillés

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

Under the Protocol established between the Foundation for Science and Technology, I.P., and the Professor Francisco Pulido Valente Foundation, applications are now open for the 2026 João Monjardino Prize, which this year is dedicated to the theme “Multimorbidity and Frailty in Older Adults: Clinical and Therapeutic Challenges.” The Prize aims to recognize the best scientific article published by a researcher affiliated with a Portuguese scientific and technological institution.